Montelukast Prescribing at STEPHENSON PARK HEALTH GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,499
Total Quantity
65.6K
NHS Cost
£3.2K
vs National Avg
+265%
STEPHENSON PARK HEALTH GROUP prescribed 2,499 items of Montelukast over the last 12 months at a cost of £3,208 to the NHS. This is 265% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
179
Jul 2026
205
Jul 2026
206
Jul 2026
216
Jul 2026
206
Jul 2026
216
Jul 2026
199
Jul 2026
226
Jul 2026
231
Jul 2026
200
Jul 2026
205
Jul 2026
210
Prescribing Details
| Total Items | 2,499 |
|---|---|
| Total Quantity | 65,580 |
| Total NHS Cost | £3,208 |
| Presentations | 4 different forms |
| vs National Average | +265% |
Montelukast Prescribing Comparison
| This practice | 2,499 items |
|---|---|
| National average per practice | 685 items |
| Difference | +265% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.